Pediatric Praziquantel Consortium awarded US$4.7 million GHIT grant
On 30 Mar 2017, the GHIT Fund announced that it will continue to support the Pediatric Praziquantel Consortium.
Read more
Events
20 March 2017
Consortium presenting at the ‘Towards Elimination of Schistosomiasis’ (TES) Conference in Cameroon
The Pediatric Praziquantel Consortium will be represented at the TES Conference that will be held on March 22-23, 2017 in Yaoundé (Cameroon).
Read more
News
16 March 2017
PLOS NTD highlights crucial role for expert meetings in NTD product development programs
Pediatric Praziquantel Consortium shares its experience with organizing expert meetings
Read more
Events
14 February 2017
‘Schistosomiasis’ featured at the ISNTD Festival
The Pediatric Praziquantel Consortium partners continue to engage with scientific and social communities in the fight against schistosomiasis. This...
Read more
News
14 November 2016
Attention for PEDPZQ Consortium in German newspapers
On October 19, Merck KGaA, Darmstadt, Germany announced the donation to the World Health Organization (WHO) of the 500 millionth tablets to treat...
Read more
News
02 November 2016
From the Program Lead: Team effort makes the difference
Reviewing the different accomplishments in the last half year fulfils me with a true sense of pride for our team. It is the combined effort from all the...
Read more
News
01 November 2016
News Digest
The News Digest provides you with compelling stories about neglected diseases, published since the release of our previous newsletter in January 2016.
Read more
News
01 November 2016
Schistosomiasis in Côte d’Ivoire: An interview with Prof. Dr. Eliézer K. N’GORAN
The Pediatric Praziquantel Consortium has initiated the Phase II clinical trial in Côte d’Ivoire, in Schistosoma mansoni-infected preschool-age...
Read more
News
01 November 2016
Think and Talk Together/ Pensar e Falar Junto
Exciting days in Rio with the extended drug product subteam
The year of the Rio de Janeiro Olympics also sees some important milestones for the...
Read more
News
01 November 2016
It’s all about access
The UK-based Schistosomiasis Control Initiative (SCI), part of Imperial College London,...
Read more
Events
17 October 2016
Consortium presenting at the ASTMH 65th Annual Meeting
In September, the Pediatric Praziquantel Consortium got acceptance of the abstract ’Outcome of two phase I relative bioavailability studies in healthy...
Read more
Press release
12 October 2016
Schistosomiasis Control Initiative and Pediatric Praziquantel Consortium join forces in the fight against schistosomiasis
Goal is to make a child-friendly treatment for schistosomiasis accessible to children under six years of age in endemic countries
